glp 1 gip dual agonist weight loss GLP-1/GIP | Tirzepatide | Obesity & T2DM Mx | Harrison's Update(22nd Ed.) PDB-101: Molecule of the Month:

Mindfulness and physical disease: a concise review

The pancreatic-endocrine-osseous axis involves a potential link between DPP-4, bone, and energy metabolism through the receptor activator of nuclear factor kappa B ligand (RANKL), which induces DPP-4 expression in osteoclasts, leading to decreased GLP-1 levels and increased blood glucose levels

Is it possible to summarize the outcomes of that trial

For patients with type 2 diabetes who are concerned about dementia risk, optimizing overall diabetes management remains the evidence-based priority

Understanding weight regain after a nutritional weight loss intervention: systematic review and meta-analysis

Its clear that we need more research evaluating the impact of these drugs on eating disorders outside of binge-eating disorders, but this could take a long time